Data as of Nov 26
| +0.04 / +0.65%|
The 5 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 18.00, with a high estimate of 20.00 and a low estimate of 12.50. The median estimate represents a +192.21% increase from the last price of 6.16.
The current consensus among 5 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.